Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Reborn Biotech is a commercial-stage biotech manufacturer specializing in the R&D and large-scale production of bioactive peptides such as fish collagen peptide, ovalbumin peptide, soybean peptide, and others. Their products are widely used in health supplements, cosmetics/beauty culture industries, and biological/medical fields. The company operates a modern facility with advanced equipment imported from Switzerland, Japan, and Germany; it has an annual output capacity of up to 50 tons per month. Their products emphasize small molecular weight for easy absorption and low impurity content. There is no evidence of clinical trials or pharmaceutical drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Reborn Biotech.